Real-Time Bioconjugation Reaction Monitoring of Antibody–Drug Conjugates with Multiattribute High-Throughput Hydrophobic Interaction Chromatography
Analytical Chemistry · 09.12.2025 · 97 (48) · 26411-26418
DOI: 10.1021/acs.analchem.5c03553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 19.11.2025. Verfasst von Lance Cadang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., South San Francisco, California 94080, United States. Hauptthemen laut MEDLINE: Immunoconjugates, High-Throughput Screening Assays. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Hydrophobic interaction chromatography (HIC) is a current gold standard for determining the drug-to-antibody ratio (DAR) and drug load distribution (DLD) in antibody-drug conjugates (ADCs). In this study, we developed several HIC methods using ammonium tartrate for comprehensive ADC characterization and bioconjugation reaction monitoring. We first demonstrated that ammonium tartrate delivers a separation performance comparable to conventional ammonium sulfate while offering superior mass spectrometry compatibility. We then established optimized platform HIC methods for analyzing both interchain and engineered cysteine-conjugated ADCs. Furthermore, we developed a rapid 10 min, multiattribute HIC method as a process analytical technology (PAT) for real-time bioconjugation reaction monitoring. This multiattribute HIC PAT method was used to simultaneously track DAR, DLD, and drug-linker (DL) concentration within complex reaction mixtures. Through advanced PAT tools, we gained critical mechanistic insights into the kinetics of ADC conjugation. For example, we discovered that the DL dissolution rate could limit reaction progression in slurry reactions, an insight not possible through conventional technologies such as ultraviolet spectroscopy. These findings enabled the identification of critical process parameters, informing targeted process development that ultimately reduced reaction times by 90% with a designed average DAR and lower undesired overconjugation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., South San Francisco, California 94080, United States.
- Pharmaceutical Technical Development, Genentech Inc., South San Francisco, California 94080, United States.
- Tosoh Bioscience LLC, King of Prussia, Pennsylvania 19406, United States.
ORCID-Profile: Andreas Stumpf, Yuchen Fan, Tao Chen, Kelly Zhang, Bingchuan Wei
Zitieren
APA
Cadang, L., Li, S., Wang, J., Stumpf, A., Kempen, T., Dai, L., Bouskila, A., Meadows, C. W., Breton, A., Yi, L., Fan, Y., Chen, T., Zhang, K., & Wei, B. (2025). Real-Time Bioconjugation Reaction Monitoring of Antibody–Drug Conjugates with Multiattribute High-Throughput Hydrophobic Interaction Chromatography. Analytical Chemistry, 97(48), 26411-26418. https://doi.org/10.1021/acs.analchem.5c03553
Vancouver
Cadang L, Li S, Wang J, Stumpf A, Kempen T, Dai L, et al. Real-Time Bioconjugation Reaction Monitoring of Antibody–Drug Conjugates with Multiattribute High-Throughput Hydrophobic Interaction Chromatography. Analytical Chemistry. 2025;97(48):26411-26418. doi:10.1021/acs.analchem.5c03553
BibTeX
@article{Cadang2025,
author = {Cadang, Lance and Li, Songman and Wang, Jenny and Stumpf, Andreas and Kempen, Trevor and Dai, Lulu and Bouskila, Alan and Meadows, Corey W and Breton, Abbie and Yi, Lian and Fan, Yuchen and Chen, Tao and Zhang, Kelly and Wei, Bingchuan},
title = {Real-Time Bioconjugation Reaction Monitoring of Antibody–Drug Conjugates with Multiattribute High-Throughput Hydrophobic Interaction Chromatography},
journal = {Analytical Chemistry},
year = {2025},
volume = {97},
number = {48},
pages = {26411--26418},
doi = {10.1021/acs.analchem.5c03553}
}
EUVIMED